| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2001 | CN1062152C Aldehyde-olefin scald medicine liquid |
| 02/21/2001 | CN1062138C RNA from poultry embryo and its medical use |
| 02/21/2001 | CN1062133C Medicine for treating hypertension |
| 02/21/2001 | CN1062132C Cream for curing eczema |
| 02/21/2001 | CN1062131C Ointment for treatment of silkworker's dermatitis |
| 02/21/2001 | CN1062129C Medicine matrix and its use |
| 02/21/2001 | CN1062128C Ointment for eliminating tinea |
| 02/20/2001 | US6191304 Vitronectin receptor antagonists |
| 02/20/2001 | US6191301 Protecting the human epidermis or human hair from ultraviolet radiation, both the a and b rays, specifically in the range from 320 to 400 nm; protect other ingredients from decomposition or breakdown by uv radiation; |
| 02/20/2001 | US6191293 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 02/20/2001 | US6191282 Derivatives of 5-membered nitrogen containing heterocyclic ring is used as anticarcinogenic agent and anticoagulant |
| 02/20/2001 | US6191279 Dipyrano-quinolinones useful as anti viral agents and a process for preparing the same |
| 02/20/2001 | US6191271 Synthetic divalent sLex containing polylactosamines and methods for use |
| 02/20/2001 | US6191266 Sugar modified nucleosides |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191172 Used in drugs and cosmetics |
| 02/20/2001 | US6191169 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/20/2001 | US6191168 Bactericides |
| 02/20/2001 | US6191167 Skin disorders |
| 02/20/2001 | US6191166 Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191164 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 02/20/2001 | US6191163 Anticonvulsant derivatives useful in lowering lipids |
| 02/20/2001 | US6191162 Administering lipoic acid |
| 02/20/2001 | US6191161 Prolylendopeptidase inhibitors |
| 02/20/2001 | US6191160 Spiro-indolines as Y5 receptor antagonists |
| 02/20/2001 | US6191159 Anticoagulants |
| 02/20/2001 | US6191158 Respiratory system disorders; cardiovascular disorders; anticholesterol agents |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/20/2001 | US6191156 Compositions and methods for treating bladder dysfunction |
| 02/20/2001 | US6191154 Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 02/20/2001 | US6191153 Schizophrenia, parkinson's disease |
| 02/20/2001 | US6191152 Cardiovascular disorders, nervous system disorders |
| 02/20/2001 | US6191151 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 02/20/2001 | US6191149 Heterocyclic derivative and medicine |
| 02/20/2001 | US6191148 Omerazole process and compositions thereof |
| 02/20/2001 | US6191147 Pyrazole compounds and uses thereof |
| 02/20/2001 | US6191146 Hemoregulatory compounds |
| 02/20/2001 | US6191144 Method of using angiotensin converting enzyme inhibitor to stimulate angiogenesis |
| 02/20/2001 | US6191143 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| 02/20/2001 | US6191142 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| 02/20/2001 | US6191141 Psychological disorders; nervous systen disorders |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/20/2001 | US6191139 Antidepressant |
| 02/20/2001 | US6191138 Therapy for respiratory system disorders |
| 02/20/2001 | US6191137 Pharmaceutical composition for oral administration |
| 02/20/2001 | US6191136 Administering xanthine oxidase inhibitor |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | US6191133 Mixture of serotonine reuptake inhibitor, noradrenaline reuptake inhibitor and folic acid |
| 02/20/2001 | US6191132 Use of quisqualate receptor antagonists |
| 02/20/2001 | US6191131 Psychological, nervous system disorders |
| 02/20/2001 | US6191130 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors |
| 02/20/2001 | US6191127 Antiinflammatory agents, autoimmune diseases, cardiovascular disorders, nervous system disorders |
| 02/20/2001 | US6191126 Topical administering |
| 02/20/2001 | US6191125 Small molecule pipecolic acid derivative hair growth compositions and uses |
| 02/20/2001 | US6191124 Methanol derivatives for treatment of retroviral infections especially HIV infections |
| 02/20/2001 | US6191123 Organic-arsenic compounds |
| 02/20/2001 | US6191121 Treatment of skin damage using polyenylphosphatidylcholine |
| 02/20/2001 | US6191120 Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions |
| 02/20/2001 | US6191119 Synergistic mixture with doxorubicin; antiproliferative agent |
| 02/20/2001 | US6191117 Methods of producing weight loss and treatment of obesity |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190901 Chicken interleukin-15 and uses thereof |
| 02/20/2001 | US6190894 Method and compositions for disrupting the epithelial barrier function |
| 02/20/2001 | US6190891 Process for producing high-molecular-weight phenolic compounds with myrothecium |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190866 Selecting bacterial target gene, preparing peptide nucleic acid having region complementary to target, identifying active peptide nucleic acid, contacting bacteria with active compounds, and determining effect on bacteria; bactericides |
| 02/20/2001 | US6190704 Regulation of wound healing by nitric oxide |
| 02/20/2001 | US6190698 Stability; discoloration inhibition; used as antipsychotic agent |
| 02/20/2001 | US6190695 Preventing or treating various bone diseases (e.g., osteoporosis); oral absorbability and stability |
| 02/20/2001 | US6190694 Rendering chitosan into powder; adding chitosan powder, powder comprising organic acid and salt thereof, and an emulsifier to an oil or fat; stirring mixture so as to suspend powders, obtain a gel-like stock and gelatin solution for encapsulation |
| 02/20/2001 | US6190693 Administering pharmaceutical formulation comprising hormonal replacememt for treating or preventing menopausal condition and folic acid |
| 02/20/2001 | US6190691 Administering formulation comprising tumor nercosis factor (tnf) production-inhibitory amount of a compound selected from loperamide and diphenoxylate to mammal |
| 02/20/2001 | US6190690 For treating arthritis, rhumatism |
| 02/20/2001 | US6190688 Material for elimination or detoxification of super antigens |
| 02/20/2001 | US6190650 For prophylaxis and therapy of viral diseases in humans and animals |
| 02/20/2001 | US6190649 Polyether-based bile acid sequestrants |
| 02/20/2001 | US6190645 Sunscreen for the scalp hair and hair |
| 02/20/2001 | US6190641 Indocyanine dyes |
| 02/20/2001 | US6190387 Spine distraction implant |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/20/2001 | CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 02/20/2001 | CA2187034C Use of amidoamines in ophthalmic compositions |
| 02/20/2001 | CA2122519C Cancer treatment and metastasis prevention |
| 02/20/2001 | CA2116617C Novel esculetin derivatives and pharmaceutical composition |
| 02/20/2001 | CA2110797C Modified sialyl lewis x compounds |
| 02/20/2001 | CA2083404C Therapeutically effective topical application of st1435 |
| 02/20/2001 | CA2076749C Vasoactive vasotocin derivatives |
| 02/20/2001 | CA2054419C Process for producing 6-(3-dimethylaminopropionyl)forskolin |
| 02/20/2001 | CA2049341C Regional chemotherapy with 4-hydroperoxycyclophosphamide |
| 02/20/2001 | CA2014569C Orally administered pharmaceutical composition for use in gastrointestinal washes, in particular for diagnostic use, or as cathartic laxative |
| 02/18/2001 | CA2302913A1 Therapeutic composition for allergic dermatitis |
| 02/15/2001 | WO2001011369A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011038A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |